What if we assessed cognitive health
by
neurophysiology,
not behavior?

Concussion Schizophrenia Traumatic Brain Injury Traumatic Brain Injury Major Depressive Disorder Major Depressive Disorder Neurodegenerative Disease Neurodegenerative Disease ADHD Mild Cognitive Impairment Mild Cognitive Impairment
Introducing
VoxNeuro CORE
A leading-edge cognitive health assessment that uses established neuropsychological and cognitive tests in combination with EEG-based brain performance software to objectively score cognitive function.
EEG-BASED COGNITIVE BIOMARKERS
0
0
0
Fast, like MoCA
Thorough, like a full neuropsych battery
Quantitative measures, evaluated against a normative database
Broadly applicable, with medical necessity across 20+ clinical conditions

VoxNeuro CORE
simplifies & accelerates

objective cognitive assessment

Reimbursable

VoxNeuro CORE
is reimbursable with
established medical necessity

Wide patient
range

Broadly applicable to clinical
conditions that affect cognition
in patients aged 12-90

Non-invasive

Rapid, non-invasive
assessment process

Accessible

Standard EEG equipment
with minimum number of
electrodes; stationary or
portable; lead-based EEGs
can be used on everyone,
irrespective of hair type

Easy to use

VoxNeuro provides training
for office staff, and does not
require EEG techs or
neuropsychs to administer

Quick results

Cloud-based software
instantly generates
patient report
Contact us to learn more.

Track cognitive changes over time

EXAMPLE:
TBI
MCI
legend
Attention & Concentration
89
Information Processing
92
Memory
76
TBI TBI
TBI Data TBI Data
Attention & Concentration
97
Information Processing
106
Memory
91
MCI MCI
MCI Data MCI Data
legend
Contact us to receive a sample report.

VoxNeuro CORE employs EEGs and established neuropsychological and cognitive tests

5 mins
Awake and Drowsy Test
3.5 mins
Auditory Evoked
Potential Test
3.5 mins
Visual Evoked
Potential Test
10 mins
Attention and Concentration & Information Processing Test
8 mins
Memory Test

Validated from end-to-end

VoxNeuro IP: Patent US 11,278,230
Normative database validated across age and sex cohorts from 12-90

Built on a legacy of
ground breaking research

Thousands of articles on ERPs, validating EEG-based cognitive
biomarkers, including top researchers with NIH funding.1

1. Donoghue, Automated meta-analysis of the event-related potential (ERP) literature, 2021
OVERALL RESEARCH
VoxNeuro's Industry-leading Research
OVERALL RESEARCH

 

 

 

VoxNeuro's Industry-leading Research

 

 

 

Contact us to learn more about the foundational research in EEG-based cognitive biomarkers.

Backed by a team of industry leaders

Contact us to get involved.

We are witnessing an unfolding brain health crisis

Between a growing and aging population and
the impact of COVID-19, there is a greater need to assess
and manage brain health and wellness.

We are witnessing an
unfolding brain health crisis

Between a growing and aging population and
the impact of COVID-19, there is a greater need to assess
and manage brain health and wellness.
TRAUMATIC BRAIN INJURIES
Approximately
2.5M
people visit the ER with TBIs each year2
COGNITIVE IMPAIRMENT
Approximately
13M
people in the US are living with mild cognitive impairment (MCI)3
TRENDS
Approximate
33%
increase in projected MCI cases among people in the US by 20303
2. Taylor et al. Traumatic Brain Injury–Related Emergency Department Visits, Hospitalizations, and Deaths — United States, 2007 and 2013. 2017
3. Rajan et al. Population Estimate of People with Clinical AD and Mild Cognitive Impairment in the United States (2020–2060). 2017
Contact us to learn more about how VoxNeuro can help you meet your patients' brain health needs.

Traditional cognitive health assessments have their place, but these approaches have limits, especially given the growing challenges

Traditional cognitive health
assessments have their place…

...but these approaches have limits,
especially given the growing challenges

MONTREAL COGNITIVE ASSESSMENT (MoCA)
Time-tested
Can be impacted by patient behavior
Fast to administer and evaluate
Valid for only certain populations9
High sensitivity for MCI4,5
Low specificity10,11
FULL NEUROPSYCHOLOGICAL BATTERIES
Comprehensive, assesses multiple domains6
Can be impacted by patient behavior
High reliability and validity in MCI7,8 and TBI7
Slower to administer12
Long lead time to receive analysis12
4. Nasreddine et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. 2005
5. Smith et al. The Montreal Cognitive Assessment: Validity and Utility in a Memory Clinic Setting. 2007
6. Roebuck-Spencer et al. Cognitive Screening Tests Versus Comprehensive Neuropsychological Test Batteries. 2017
7. Liew. Developing a Brief Neuropsychological Battery for Early Diagnosis of Cognitive Impairment. 2019
8. Jacova et al. Neuropsychological Testing and Assessment for Dementia. 2007
9. Hobson. The Montreal Cognitive Assessment (MoCA). 2015
10. Dautzenberg et al. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry. 2020
11. Davis et al. Montreal Cognitive Assessment (MoCA) for the detection of dementia. 2021
12. Roebuck-Spencer et al. Cognitive Screening Tests Versus Comprehensive Neuropsychological Test Batteries. 2017

Overcome these limitations
with VoxNeuro CORE brain performance software.

Giving everyone's brain a voice